|4Aug 16, 4:01 PM ET

Bernard Thierry 4

4 · T2 Biosystems, Inc. · Filed Aug 16, 2023

Insider Transaction Report

Form 4
Period: 2023-01-01
Transactions
  • Exercise/Conversion

    Common Stock

    2023-08-06+4545,022 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-08-064540 total
    Common Stock (454 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-01-011,5500 total
    Common Stock (1,550 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-01+1,5504,568 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]On January 1, 2022 the reporting person was granted 1,550 RSU's that vested in one installment on January 1, 2023.
  • [F3]On August 6, 2020 the reporting person was granted 1,363 RSU's that vest in three equal annual installments beginning on August 6, 2021.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4